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OBJECTIVES: To compare the metabolic, hemodynamic, autonomic, and endothelial responses to short-term red wine consump-
tion in subjects with hypercholesterolemia or arterial hypertension, and healthy controls.
METHODS: Subjects with hypercholesterolemia (n=10) or arterial hypertension (n=9), or healthy controls (n=7) were given red 
wine (250 mL/night) for 15 days. Analyses were performed before and after red wine intake.
RESULTS: Red wine significantly increased the plasma levels of HDL-cholesterol in the controls, but not in the other groups. 
The effects on hemodynamic measurements were mild, non-significantly more prominent in healthy subjects, and exhibited high 
interindividual variability. Across all participants, mean blood pressure decreased 7 mmHg (p <0.01) and systemic vascular resis-
tance decreased 7% (p = 0.05). Heart rate and cardiac output did not significantly change in any group. Red wine enhanced muscle 
sympathetic fibular nerve activity in hypercholesterolemic and hypertensive patients, but not in controls. At baseline, brachial artery 
flow-mediated dilation was impaired in patients with hypercholesterolemia and arterial hypertension; red wine restored the dilation 
in the hypercholesterolemic group but not in the hypertensive group.
CONCLUSIONS: Red wine elicits different metabolic, autonomic, and endothelial responses among individuals with hypercho-
lesterolemia or arterial hypertension and healthy controls. Our findings highlight the need to consider patient characteristics when 
evaluating the response to red wine.
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INTRODUCTION
Several studies have documented a protective role of 
moderate wine consumption (15.5 to 31 g alcohol/day) 
in both vascular and nonvascular diseases.1-3 Different 
mechanisms may be responsible for these beneficial effects, 
including increases in HDL-cholesterol plasma levels,4 
decreased platelet aggregation,5 antioxidant effects,6 and 
restoration of endothelial function by flavonoids.7,8
On the other hand, high alcohol intake (> 31 g alcohol/
day) is associated with undesirable consequences, such 
as elevation of blood pressure9,10 and activation of the 
sympathetic system.11 Epidemiological studies consistently 
show a J-shaped relation between alcohol consumption and 
total mortality.3
We have previously shown that red wine and purple grape 
juice restore endothelial function in hypercholesterolemic 
individuals without any additional risk factors.8 It is not 
well known whether this beneficial effect is reproducible 
in people with other conditions that may be associated with 
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endothelial dysfunction such as arterial hypertension. In 
fact, the influence of different risk factors on the various 
properties of red wine has not been fully investigated. 
Studies comparing the different effects of red wine in 
populations with different characteristics are lacking.
We have put forward the hypothesis that the effects 
of red wine on different aspects related to cardiovascular 
disease may differ according to individual characteristics, 
specifically whether the subject is hypertensive or 
hypercholesterolemic.
Hence, the purpose of this study was to compare the 
effects of 15 days of red wine consumption on the lipid 
profile, hemodynamic profile, sympathetic activity, and 
endothelial function of patients with hypercholesterolemia 
or arterial hypertension and in healthy controls.
MATERIALS AND METHODS
Subjects and protocol
Ten subjects with hypercholesterolemia (HCHOL group), 
nine with arterial hypertension (AH group), and seven with 
neither hypercholesterolemia nor arterial hypertension 
(healthy controls) were enrolled. Arterial hypertension was 
defined as blood pressure (BP) >140/90mm Hg, according 
to the Seventh Report of the Joint National Committee on 
Prevention, Detection, Evaluation, and Treatment of High 
Blood Pressure.12 Hypercholesterolemia was defined as a 
plasma LDL-cholesterol >160 mg/dL. None of the subjects 
had clinical evidence of any serious disease or condition 
that alters sympathetic activity such as diabetes mellitus; 
heart, liver, or renal failure; obesity; smoking; old age (>65 
years); or peripheral neuropathies. They were asked not to 
ingest products containing caffeine or polyphenols, such as 
fruit, coffee, tea, and alcoholic beverages other than the wine 
used in the study, during the 72 hours preceding the protocol 
examinations. They were encouraged not to change their 
daily dietary habits otherwise. They were not taking statins, 
and they were told to stop taking any antihypertensive 
drugs three weeks before the beginning of the protocol. Any 
possible harmful effects of medication withdrawal were 
monitored with periodic blood pressure (BP) measurements 
and active questioning of the subjects.
Blood collection (after a 12-hour overnight fast), analyses 
of endothelial function (in the morning) and sympathetic 
activity (at least 2 hours after lunch) were all conducted on 
the same day. Individuals were then provided with a supply 
of red wine (Varietal, Vinícola Aurora, Rio Grande do Sul, 
Brazil) and instructed to drink 250 mL each night, after a 
meal, for 15 consecutive days. After this period, evaluation 
of both endothelial function and sympathetic activity was 
repeated. Endothelial function was also reassessed 15 days 
after the discontinuation of red wine consumption (washout 
period) in 14 subjects.
Written informed consent was obtained from all 
participants. The ethics committee of the Heart Institute 
(InCor) and Hospital das Clínicas of the University of São 
Paulo Medical School approved the protocol.
Blood analysis
Plasma levels of total cholesterol, HDL-cholesterol, 
LDL-cholesterol, triglycerides, and glucose were determined 
by enzymatic methods (Roche Laboratories, Basel, 
Switzerland).
Microneurography protocol
Muscle sympathetic nerve activity (MSNA) was assessed 
by direct multiunit recordings of postganglionic sympathetic 
activity of the fibular nerve. The procedure involved selective 
insertion of unipolar tungsten microelectrodes into nerve 
fibers in the muscle, posterior to the fibular head, according 
to a previously described technique.13 Filtered and mean 
neurograms were recorded on millimetered paper. Muscle 
sympathetic bursts were identified by visual inspection by 
a single blinded investigator (F.C.C.) and were expressed as 
bursts per minute.
After placement of the electrode, the patient rested 
for 10 minutes to ensure that the BP, heart rate (HR), and 
MSNA were at basal levels. MSNA was then recorded for 
10 minutes. After that, a cold pressor stimulus, consisting of 
immersion of the hand up to the wrist into ice water for 2 
minutes, was initiated. After recording MSNA, this stimulus 
was followed by another 10-minute rest period to ensure 
that BP, HR, and MSNA returned to basal conditions. The 
subjects were then engaged in an isometric exercise, which 
involved pulling a dynamometer at 30% of the subject’s 
maximum effort for 2 minutes, and MSNA was again 
determined.
Hemodynamic variables
During the microneurography protocol, HR, BP, 
and electrocardiography (DII lead) were continuously 
monitored. BP was measured noninvasively, beat-to-beat, 
using a photoplethysmographic finger device (Portapres, 
Finapres Medical Systems, The Netherlands). This 
method is based on a volume-clamp technique, and the 
mean BP is obtained as the integral of pressure over 
each beat divided by the corresponding beat interval.14,15 
Measurements were transferred to a computer for calculation 
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of several hemodynamic variables (including cardiac 
output and systemic vascular resistance) using commercial 
software (BeatScope 1.1, Finapres Medical Systems, The 
Netherlands).
Brachial artery reactivity protocol
Brachial artery ultrasound studies were performed to 
assess endothelial function by measuring flow-mediated 
dilation (FMD) induced by reactive hyperemia as previously 
described8 and according to current guidelines.16 Studies 
were performed after the patient had rested for 10 minutes 
in a temperature-controlled room (20° to 25°C) using a 
7.5-MHz linear array vascular ultrasound transducer and an 
APOGEE 800 plus ATL ultrasound system (ATL Ultrasound, 
Bothell, WA, USA).
The left brachial artery was imaged 2 to 15 cm above 
the elbow and scanned in longitudinal section with the 
focus zone set to the depth of the near wall. During image 
acquisition, anatomic landmarks such as fascial planes 
were noted to help record the same image of the artery 
throughout the study. Vessel diameter was measured using 
specific software developed at the Heart Institute (São Paulo, 
Brazil) that uses a semiautomatic approach to measure artery 
diameter based on an active contour technique supplemented 
by multiresolution analysis8. The blinded operator selected 
a region of interest (0.39 inch in longitudinal diameter) in 
6 series of brachial artery images obtained from B-mode 
ultrasound. The distance between the near and far wall 
media-adventitia during diastole was obtained for all images, 
and the average was calculated.
Reactive hyperemia was induced by inflation of a 
pneumatic BP tourniquet, placed around the forearm, to 
a systolic BP of 250mm Hg, followed by deflation after 5 
minutes. FMD was calculated as the ratio of the brachial 
artery diameter after reactive hyperemia to the baseline 
diameter, expressed as percent variation.
Endothelium-independent vasodilation was assessed 
by administration of sublingual isosorbide dinitrate (5 mg) 
and calculated in an analogous fashion. The average of two 
measurements was taken.
Statistical analysis
Continuous variables were reported as mean ± standard 
deviation (SD), unless otherwise noted. Data were compared 
using the paired Student’s t test or analysis of variance 
(ANOVA) with repeated measurements, and post hoc 
analyses were performed to determine differences between 
two groups and/or two moments (for instance, after vs. 
before red wine intake).
Correlation analyses were also performed to assess 
interdependence between changes in different variables after 
red wine intake.
The level of significance was taken to be p < 0.05 for all 
analyses.
RESULTS
Clinical and laboratory data
Table 1 summarizes the clinical and laboratory 
characteristics of the three groups before and after red wine 
consumption. Groups were comparable in terms of gender 
and age distributions. As expected, the HCHOL group 
exhibited higher plasma levels of total cholesterol and LDL-
cholesterol compared with the AH and control groups and 
higher plasma concentrations of triglycerides compared 
with controls. Both the AH and HCHOL groups exhibited 
higher glucose levels than the controls, and the hypertensive 
Table 1 - Clinical and laboratory data of patients before and after red wine intake
Hypercholesterolemia (n=10) Arterial hypertension (n=9) Control (n=7)
Before red wine After red wine Before red wine After red wine Before red wine After red wine
Sex (men/women) 7/3 7/2 5/2
Age (years) 43.2 ± 6.9 45.1 ± 7.4 37.3 ± 7.2
BMI (kg/m2) 25.6 ± 2.9 25.8 ± 3.0 27.9 ± 1.9d 28.1 ± 1.9 24.5 ± 2.9 24.4 ± 2.7
Total cholesterol (mg/dL) 259 ± 19a 242 ± 37 199 ± 45 192 ± 51 172 ± 23 194 ± 38
LDL-cholesterol (mg/dL) 181 ± 17a 164 ± 31 131 ± 38 117 ± 39 106 ± 15 119 ± 27
HDL-cholesterol (mg/dL) 53 ± 9 49 ± 9 47 ± 10 48 ± 10 52 ± 12 59 ± 16e
Triglycerides (mg/dL) 126 ± 46b 139 ± 66 100 ± 36 131 ± 51e 70 ± 24 81 ± 30
Glucose (mg/dL) 97 ± 9 99 ± 10 97 ± 8 101 ± 9 88 ± 7c 91 ± 5
BMI: body mass index; Data are reported as mean ± SD; a p <0.01 vs. AH or control before red wine; b p = 0.04 vs. control before red wine; c p ≤0.04 vs. 
AH or HCHOL before red wine; d p = 0.03 vs. control before red wine; e p = 0.02 vs. before red wine
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individuals recorded a higher average body mass index than 
the controls.
When all patients were grouped together, red wine intake 
significantly increased plasma concentrations of triglycerides 
(21%, p <0.01) and glucose (3%, p = 0.03). A significant 
elevation in HDL-cholesterol plasma levels after red wine 
intake was observed only in the healthy controls (14%, p = 
0.02).
Hemodynamic measurements and sympathetic activity
Resting condition
Before red wine intake, systolic BP was significantly 
higher in the AH group compared with controls. Also, 
diastolic BP was nonsignificantly higher in the AH group 
than in the other groups, and, as expected, mean BP was 
significantly higher in the AH group than in the other groups 
(Table 2). This finding was not associated with significant 
differences in resting MSNA among the three groups (Table 
3).
Although red wine markedly increased resting MSNA 
in the HCHOL and AH groups, the variation in healthy 
controls was minimal (Table 3). Indeed, after red wine 
intake, the peripheral sympathetic system was significantly 
more activated in the hypertensive and hypercholesterolemic 
individuals than in the healthy controls (Table 3).
In contrast with this sharp increase in sympathetic 
activity in the HCHOL and AH groups, the hemodynamic 
consequences of red wine were mild, non-significantly more 
prominent in healthy subjects (Table 2), and characterized by 
a high interindividual variability, especially in the HCHOL 
and AH groups.
Grouping all the patients together, red wine reduced 
systolic BP from 143 ± 13 mmHg to 138 ± 13 mmHg (p 
= 0.01), diastolic BP from 84 ± 9 mmHg to 78 ± 8 mmHg 
(p <0.01), and mean BP from 108 ± 11 mmHg to 101 ± 10 
mmHg (p <0.01). This effect was likely driven by a fall in 
systemic vascular resistance, which decreased 7% across all 
patients (p = 0.05 vs. before red wine), 1% in the HCHOL 
group, 8% in the AH group, and 17% in the controls (p = ns 
for comparison among groups). No significant change was 
found in the variation of the cardiac output or HR after red 
wine consumption in any group (Table 2).
No correlation was detected between the variation in 
resting MSNA (after vs. before red wine) and either the 
change in mean BP or systemic vascular resistance.
Effects of cold stimulus
As expected, cold stimulus increased MSNA (26% 
before, 36% after red wine intake, p ≤0.01 vs. resting 
condition, across all patients).
Before the red wine intake, cold stimulus caused systolic 
Table 2 - Hemodynamic data at rest, before and after red wine intake
Hypercholesterolemia (n=10) Arterial hypertension (n=9) Control (n=7)
Before red wine After red wine Before red wine After red wine Before red wine After red wine
Heart rate (bpm) 68 ± 9 68 ± 11 76 ± 14 75 ± 10 69 ± 13 71 ± 6
Systolic BP (mmHg) 141 ± 15 135 ± 12 153 ± 8a 149 ± 8c 134 ± 6 129 ± 8
Diastolic BP (mmHg) 80 ± 11 75 ± 7 89 ± 5 85 ± 6c 83 ± 7 73 ± 7 e
Mean BP (mmHg) 104 ± 13 97 ± 8 116 ± 6b 111 ± 6d 103 ± 9 94 ± 6e
Cardiac output (L/min) 6.32 ± 1.25 6.14 ± 1.08 6.19 ± 0.98 6.55 ± 1.26 5.70 ± 1.37 6.46 ± 1.27
Systemic vascular resistance 
(dyne.s.cm-5)
1037 ± 291 981 ± 170 1208 ± 283 1072 ± 283 1158 ± 386 919 ± 245
BP: blood pressure; Data are reported as mean ± SD; a p = 0.01 vs. control before red wine; b p <0.01 vs. HCHOL or control before red wine; c p ≤0.03 
vs. control after red wine; d p <0.01 vs. HCHOL or control after red wine; e p ≤0.03 vs. before red wine
Table 3 - Muscle sympathetic nerve activity (bursts/min) before and after red wine intake
Hypercholesterolemia (n=10) Arterial hypertension (n=9) Control (n=7)
Before red wine After red wine Before red wine After red wine Before red wine After red wine
Rest 27.0 ± 6.8 49.9 ± 5.5a 30.0 ± 8.0 42.7 ± 9.6 26.6 ± 7.1 26.9 ± 8.8b
Cold stimulus 31.2 ± 6.5 62.9 ± 9.2a 36.9 ± 11.1 58.1 ± 11.9a 33.9 ± 5.0 37.4 ± 6.6c
Isometric exercise 34.4 ± 9.1 55.8 ± 10.9a 36.1 ± 15.9 51.2 ± 13.6a 31.1 ± 5.8 37.4 ± 7.4d
Data are reported as mean ± SD; a p ≤ 0.02 vs. before red wine; b p ≤ 0.02 vs. HCHOL or AH at rest, after red wine; c p < 0.01 vs. HCHOL or AH at cold 
test, after red wine; d p < 0.01 vs. HCHOL at isometric exercise, after red wine
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and diastolic BP to increase 21 ± 10% and 19 ± 10%, 
respectively (p ≤0.01 vs. resting condition, considering all 
patients). After consuming red wine, the corresponding 
values were 23 ± 10% and 21 ± 9% (p ≤0.01 vs. resting 
condition, across all patients). There was no significant 
difference among the three groups in terms of blood pressure 
variation with the cold stimulus either before or after red 
wine intake.
Although it did not attain statistical significance, the 
increase in systemic vascular resistance with the cold 
stimulus was less pronounced after vs. before red wine, 
especially in healthy subjects. In the HCHOL group, the 
increase was 20% before and 12% after red wine; in the AH 
group, the numbers were 46% and 40%, respectively; in 
controls, 22% and 7%, respectively.
Effects of isometric exercise
As expected, isometric exercise increased MSNA (31% 
before, 26% after red wine intake, p ≤0.02 vs. resting 
condition, across all patients). The effects of isometric exercise 
on hemodynamic measurements were more modest than those 
reported for the cold test. Before red wine intake, grouping all 
the patients together, both systolic and diastolic BP increased 
7% (p <0.01), and systolic vascular resistance increased 
6% (p = 0.07). The magnitude of these isometric exercise-
induced variations was unchanged by red wine. In addition, no 
significant difference was observed among the groups.
Brachial artery reactivity
Before red wine intake, FMD was nonsignificantly 
lower in the HCHOL and AH groups compared to the 
controls (Figure 1). Red wine restored FMD in the HCHOL 
group, but not in the AH group. Endothelium-independent 
vasodilation was nonsignificantly impaired in the AH group 
compared with the HCHOL group and controls, both before 
or after red wine consumption.
We also sought to evaluate the subset of 14 individuals 
who performed the brachial artery reactivity test after a 
washout period. In five HCHOL subjects, the FMD was 
6.9 ± 12.3% at the beginning of the study, increased to 
14.7 ± 2.8% after red wine, and fell to -0.4 ± 7.4% after 
red wine washout, indicating, on average, an absence of 
FMD following red wine withdrawal. In seven hypertensive 
patients, FMD was 4.7 ± 1.5%, 5.2 ± 5.7%, and 3.6 ± 
2.2 % before red wine, after red wine, and after washout, 
respectively. In two healthy subjects, the respective dilations 
were 13.1 ± 1.7%, 15.8 ± 1.9%, and 14.8 ± 6.1%.
There was no correlation between changes in either 
MSNA or systemic vascular resistance (after vs. before red 
wine intake) and variation in FMD.
DISCUSSION
Numerous cross-sectional, observational, and controlled 
studies reveal a range of red wine effects on different 
aspects related to cardiovascular disease.3,17 Other studies 
show the relations of essential hypertension and coronary 
disease with genetic background,18 capillary density,19 and 
blood levels of cholesterol.20,21 Most of these studies have 
addressed one or a few outcomes, and not several at the 
same time, as in the current investigation. Moreover, most 
of the previous controlled trials have enrolled only healthy 
people17 and have not compared different populations 
simultaneously.
Our objectives were to compare the metabolic, 
hemodynamic, autonomic, and endothelial responses to 
red wine in subjects with hypercholesterolemia or arterial 
hypertension, or in healthy controls with neither of these risk 
factors. Several major findings are contributed by this study: 
(1) red wine increased plasma HDL-cholesterol levels only 
in the control group; (2) red wine slightly decreased mean 
BP in all groups, which was associated with a borderline-
significant fall in systemic vascular resistance; (3) red wine 
caused a significant increase in sympathetic activity in the 
HCHOL and AH groups but not in controls; and (4) red 
wine restored FMD in the HCHOL group but not in the AH 
group.
Figure 1 - Brachial artery flow-mediated (A) and nitroglycerin-mediated 
(B) dilation before and after red wine intake. Values are shown as means ± 
standard errors. AH: arterial hypertension; HCHOL: hypercholesterolemia. 
* p = 0.01 before vs. after red wine in the HCHOL group
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Metabolic changes
Several studies have documented the effects of alcoholic 
beverages on lipid metabolism.17 In particular, the HDL-
cholesterol-raising property of red wine seems to be 
primarily dependent on the alcoholic content, given that 
one head-to-head comparison shows that red wine, but 
not red grape extract, increases blood HDL-cholesterol 
concentrations.22
In a meta-analysis of studies evaluating different ethanol-
containing drinks in mostly healthy individuals, Rimm 
et al.17 reported that 30 g of ethanol per day increases the 
plasma concentration of HDL-cholesterol by 4 mg/dL and of 
triglycerides by 6 mg/dL. Thus, the increase in triglyceride 
levels that we observed is consistent, although more than 
3-fold higher, than that reported by Rimm et al.17
The present study revealed that the increase in plasma 
HDL-cholesterol concentration was restricted to healthy 
subjects. In a previous investigation, we also observed 
no increase in HDL-cholesterol levels after 14 days of 
red wine ingestion in individuals with a high baseline 
plasma concentration of total cholesterol.8 One possible 
explanation for this finding is related to individuals being 
overweight or obese. In our cohort, healthy controls were 
thinner than the hypercholesterolemic or hypertensive 
patients. Interestingly, Hagiage et al.23 demonstrated that 
wine (30 g ethanol for 14 days) increases apolipoprotein 
A1 and decreases cholesteryl ester transfer protein activity 
in normoponderal but not in obese subjects, suggesting that 
obesity-associated abnormalities impair the effects of wine 
on HDL metabolism.
The very mild elevation in plasma glucose levels after 
red wine intake and the short-term nature of this study 
do not allow speculation as to the possible undesirable 
consequences of long-term alcohol intake on glucose 
metabolism. However, available data from the literature 
point in the opposite direction: population studies show that 
low-to-moderate regular alcohol intake decreases insulinemia 
and improves insulin sensitivity.24,25 In addition, alcohol 
consumption was recently inversely associated with the risk 
of type 2 diabetes in women in a case-control study.26
Hemodynamic measurements
Chronic heavy alcohol ingestion is consistently associated 
with hypertension.3 Although more controversial, moderate 
alcohol/red wine consumption is also believed to raise blood 
pressure, although an acute, transitory fall is reported to 
happen in the first hours after alcohol ingestion.9,10,17
Our study does not support the belief that moderate, 
short-term red wine consumption increases BP. Despite a 
high interindividual variability in our hemodynamic data that 
prevents definitive conclusions, red wine intake decreased 
the average BP in association with a quasi-significant fall 
in systemic vascular resistance. Interestingly, this decrease 
in BP was not observed in our previous investigation, using 
a very similar protocol.8 Differences in the type of wine 
used and the manner of measuring BP (standard pneumatic 
method in the forearm vs. plethysmographic finger device) 
may explain these contrasting results.
Importantly, the decrease in systemic vascular resistance 
cannot be attributed to changes in either sympathetic activity 
or endothelial function, suggesting a direct vasodilatory 
action of red wine. The less-pronounced elevation in 
systemic vascular resistance with the cold test after red wine 
consumption is also consistent with a vasodilatory property 
of red wine.
It is interesting to note that red wine increased 
sympathetic outflow only in the HCHOL and AH groups, 
whereas hemodynamic changes (decreases in BP and 
systemic vascular resistance) were nonsignificantly less 
expressive in these groups, as compared to controls. In 
addition, the attenuating effect of red wine on the increase 
in systemic vascular resistance with cold stimulus was 
more evident in healthy individuals. Although we found 
no correlation among variations (after vs. before red 
wine) in terms of MSNA, systemic vascular resistance, 
and FMD, these observations allow us to suggest that 
red wine decreases systemic vascular resistance and BP 
through a direct vasodilatory effect, but that activation of 
the sympathetic system (possibly by alcohol) blunts these 
hemodynamic effects.
Sympathetic activity
Previous studies27,28 have shown that acute alcohol 
or red wine ingestion increases sympathetic activity in 
healthy volunteers, in disagreement with the lack of 
increase in MSNA in our control group. It is possible that 
this discrepancy reflects the longer duration of and more 
moderate nature of alcohol intake in our study.
The reason why red wine increased MSNA in the 
HCHOL and AH groups but not in controls is not clear. 
Although speculative, it may be true that individuals with 
lipid disorders and those with hypertension share some 
abnormality that is responsible for the different effects of 
ethanol or red wine on autonomic activity, compared with 
normal individuals. A very reasonable candidate is the 
baroreflex dysfunction, which is known to be a feature of 
arterial hypertension and other conditions closely related to 
lipid abnormalities such as coronary artery disease, diabetes 
mellitus, obesity, and metabolic syndrome.29 Accordingly, 
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baroreceptor impairment may be implicated in some ethanol 
effects.30 Therefore, the baroreflex dysfunction might be the 
link between red wine intake and increased MSNA in the 
HCHOL and AH groups, but not in healthy persons.
Endothelial function
The increase in FMD after red wine consumption 
in hypercholesterolemic subjects confirms our previous 
findings8 and supports the results of other studies that show 
acute benefits of wine or de-alcoholized red wine on the 
endothelium in patients with coronary artery disease.31,32 In 
the present study, in particular, the obvious fall in FMD after 
the washout period (this actually suggests a rebound effect) 
clearly supports a beneficial role of red wine components as 
they impact the endothelium in this population. This effect is 
most likely related to higher nitric oxide bioavailability.33, 34
The lack of improvement in endothelial function in 
our hypertensive patients should be confirmed with further 
studies. Assuming endothelial dysfunction is an accepted 
marker of early atherosclerosis and has prognostic relevance, 
35
 this finding has important clinical implications. We note, 
however, that endothelium-independent vasodilation was 
nonsignificantly lower in the AH group, which might have 
influenced the results of the reactive hyperemia.
Although our study failed to determine why the endothelial 
response to red wine was inconsistent between individuals 
with hypercholesterolemia or hypertension, we suggest that 
different mechanisms may account for endothelial dysfunction 
under such conditions. In support of this possibility, two 
studies from the same group have demonstrated that, in 
patients with essential hypertension, endothelium-dependent 
vasodilation in response to bradykinin is impaired. This 
contrasts with a preserved response to bradykinin in 
hypercholesterolemic subjects.36,37
Limitations
Our sample size may not have been sufficiently large to 
detect certain differences in the effects of red wine among the 
groups. We emphasize that this study evaluated the effects 
of short-term red wine intake, and our conclusions should 
not be extrapolated to longer-term ingestion scenarios. 
Endothelial function was analyzed using only one method, 
as was sympathetic activity. Mechanistic investigations, 
such as those involved in baroreflex dysfunction, were not 
performed. The lack of measurement of concentrations of 
resveratrol, catechin, or quercetin in plasma or urine does 
not allow us to reach firm conclusions regarding the effects 
of flavonoids in this study.
CONCLUSIONS
This study highlights the existence of significant 
variability in the effects of red wine on different patient 
groups. Elevation in HDL-cholesterol levels was noted only 
in healthy subjects, but not in those with arterial hypertension 
or high total cholesterol levels. Hemodynamic consequences 
of red wine intake were somewhat variable among subjects 
across all groups; on average, red wine decreased mean 
BP, probably due to a direct vasodilatory action. Red 
wine activated the sympathetic system in individuals with 
hypercholesterolemia or arterial hypertension, but not in 
healthy controls. In terms of improving endothelial function, 
individuals with hypertension do not benefit from red wine 
as hypercholesterolemic subjects do. 
Further investigations involving larger samples are 
required to confirm and understand the mechanisms involved 
in these findings and, consequently, to provide therapeutic 
implications. So far, the results reinforce the need for us to 
consider patient characteristics when evaluating the medical 
properties of red wine.
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